We are live on ! Find out more
FTH

Faeth Therapeutics
FTH

42 hedge funds and large institutions have $8.21M invested in Faeth Therapeutics in 2022 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 9 increasing their positions, 15 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

83% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 6

14% more funds holding

Funds holding: 37 → 42 (+5)

0.02% more ownership

Funds ownership: 0.56% → 0.58% (+0.02%)

40% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 15

58% less capital invested

Capital invested by funds: $19.7M → $8.21M (-$11.5M)

Holders
42
Holders Change
+5
Holders Change %
+13.51%
% of All Funds
0.66%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
9
Reduced
15
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$331K
2
HighTower Advisors
HighTower Advisors
Illinois
+$200K
3
BCM
Bridgeway Capital Management
Texas
+$151K
4
Two Sigma Investments
Two Sigma Investments
New York
+$133K
5
Bank of America
Bank of America
North Carolina
+$91.4K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$149K
2
BlackRock
BlackRock
New York
-$138K
3
Morgan Stanley
Morgan Stanley
New York
-$102K
4
VF
Virtu Financial
New York
-$93K
5
CSS
Cubist Systematic Strategies
Connecticut
-$74K
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$2.7M -$138K -1,735 -3%
Vanguard Group
2
Vanguard Group
Pennsylvania
$1.75M +$8.99K +113 +0.3%
Geode Capital Management
3
Geode Capital Management
Massachusetts
$590K -$2.79K -35 -0.3%
State Street
4
State Street
Massachusetts
$521K +$60.8K +764 +7%
JP Morgan Chase
5
JP Morgan Chase
New York
$361K -$13.6K -171 -2%
Northern Trust
6
Northern Trust
Illinois
$356K -$22.7K -285 -4%
DFO
7
Duquesne Family Office
New York
$231K – – –
Renaissance Technologies
8
Renaissance Technologies
New York
$192K +$331K +4,160 New
Two Sigma Investments
9
Two Sigma Investments
New York
$144K +$133K +1,670 +116%
N
10
Nuveen
North Carolina
$133K +$3.66K +46 +2%
Bank of New York Mellon
11
Bank of New York Mellon
New York
$126K -$5.41K -68 -2%
Truist Financial
12
Truist Financial
North Carolina
$117K – – –
HighTower Advisors
13
HighTower Advisors
Illinois
$116K +$200K +2,511 New
Millennium Management
14
Millennium Management
New York
$115K -$149K -1,878 -43%
Bank of America
15
Bank of America
North Carolina
$110K +$91.4K +1,148 +92%
Charles Schwab
16
Charles Schwab
California
$102K – – –
Two Sigma Advisers
17
Two Sigma Advisers
New York
$94K +$83.2K +1,045 +105%
BCM
18
Bridgeway Capital Management
Texas
$88K +$151K +1,895 New
RhumbLine Advisers
19
RhumbLine Advisers
Massachusetts
$37K -$10.9K -137 -14%
LB
20
Leo Brokerage
Texas
$34K +$59K +742 New
UBS Group
21
UBS Group
Switzerland
$31K -$34.9K -439 -39%
RJA
22
Raymond James & Associates
Florida
$30K +$51.7K +650 New
Goldman Sachs
23
Goldman Sachs
New York
$29K +$6.29K +79 +14%
Deutsche Bank
24
Deutsche Bank
Germany
$26K -$5.33K -67 -11%
Morgan Stanley
25
Morgan Stanley
New York
$25K -$102K -1,288 -70%
1
2

FTH Hedge Fund Activity: Q1 2022 in Review

42 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Faeth Therapeutics (FTH) for Q1 2022, worth a combined $8.21M — down 58% from $19.7M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new FTH positions and 6 closed out — a net gain of 5 holders — while 9 added to existing stakes and 15 trimmed.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $331K. The largest seller was Millennium Management, cutting an estimated $149K.

  • 42 institutional investors held Faeth Therapeutics (FTH) as of Q1 2022, up from 37 in Q4 2021.
  • Funds reported $8.21M of Faeth Therapeutics stock for Q1 2022, down 58% quarter-over-quarter.
  • 11 funds opened new Faeth Therapeutics positions in Q1 2022 and 6 closed out, a net change of +5 holders.
  • The largest Faeth Therapeutics buyer in Q1 2022 was Renaissance Technologies, an estimated $331K added.
  • The largest Faeth Therapeutics seller in Q1 2022 was Millennium Management, an estimated $149K sold.

Based on aggregated 13F filings for Q1 2022.